相关实验视频

Updated: Jun 7, 2025

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

代谢药物用于增强对炎症性肠病的临床理解

Theresa Louise Boye¹, Alexander Hammerhøj¹, Ole Haagen Nielsen¹

¹Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Denmark.

|November 13, 2024

概括

代谢学,即对代谢物的研究,为精准医学提供了宝贵的见解. 像质谱和NMR光谱等技术可以增强临床决策,特别是复杂的疾病,如炎症性肠病 (IBD).

科学领域:

代谢学和多种生物学的系统生物学.
在精密医学中的临床应用.

背景情况:

代谢学涉及对生物样本中的代谢物进行系统的识别和量化.
精准医学利用多组学 (基因组学,转录组学,蛋白质组学,表观组学,代谢组学) 进行个性化诊断和治疗.
由于遗传和环境因素,炎症性肠病 (IBD) 的预后和治疗反应是可变的.

研究的目的:

为提供质谱学 (MS) 和质子核磁共振 (1H NMR) 谱学用于代谢学的技术概述.
讨论最近的临床进展和这些代谢技术的应用.
突出代谢学在改善IBD等疾病的临床决策方面的潜力.

主要方法:

对代谢学质谱 (MS) 技术的审查.
对质子核磁共振 (1H NMR) 光谱技术对代谢学进行审查.
讨论MS和1H NMR在代谢学中的临床进展和应用.

主要成果:

代谢技术,包括MS和1HNMR,对于识别和量化代谢物是有价值的.
这些技术有望提高诊断分类,疾病监测和精准医学中的治疗选择.
准代谢组可能为区分和分析IBD和其他复杂疾病的患者提供关键见解.

结论:

代谢技术对于精准医学的进步至关重要.
多发性硬化和1H NMR是具有显著临床潜力的代谢测量关键技术.
需要通过代谢学来改进的诊断方法,以改善患者对IBD等临床表现重叠的疾病的护理.

关键词:

(1) 在H NMR光谱学中使用H NMR光谱.炎症性肠病是一种炎症性肠病.质谱测量质量谱测量代谢学代谢学代谢学

更多相关视频

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...